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Abstract
The Major Histocompatibility Complex (MHC, 6p21) codes for traditional HLA and other host response related genes. The
polymorphic HLA-DRB1 gene in MHC Class II has been associated with several complex diseases. In this study we focus on
MHC haplotype structures in the Finnish population. We explore the variability of extended HLA-DRB1 haplotypes in relation
to the other traditional HLA genes and a selected group of MHC class III genes. A total of 150 healthy Finnish individuals
were included in the study. Subjects were genotyped for HLA alleles (HLA-A, -B, -DRB1, -DQB1, and -DPB1). The
polymorphism of TNF, LTA, C4, BTNL2 and HLA-DRA genes was studied with 74 SNPs (single nucleotide polymorphism). The
C4A and C4B gene copy numbers and a 2-bp silencing insertion at exon 29 in C4A gene were analysed with quantitative
genomic realtime-PCR. The allele frequencies for each locus were calculated and haplotypes were constructed using both
the traditional HLA alleles and SNP blocks. The most frequent Finnish A,B,DR -haplotype, uncommon in elsewhere in
Europe, was A*03,B*35,DRB1*01:01. The second most common haplotype was a common European ancestral haplotype
AH 8.1 (A*01,B*08,DRB1*03:01). Extended haplotypes containing HLA-B, TNF block, C4 and HLA-DPB1 strongly increased
the number of HLA-DRB1 haplotypes showing variability in the extended HLA-DRB1 haplotype structures. On the contrary,
BTNL2 block and HLA-DQB1 were more conserved showing linkage with the HLA-DRB1 alleles. We show that the use of HLA-
DRB1 haplotypes rather than single HLA-DRB1 alleles is advantageous when studying the polymorphisms and LD patters of
the MHC region. For disease association studies the HLA-DRB1 haplotypes with various MHC markers allows us to cluster
haplotypes with functionally important gene variants such as C4 deficiency and cytokines TNF and LTA, and provides
hypotheses for further assessment. Our study corroborates the importance of studying population-specific MHC haplotypes.
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Introduction
The Major Histocompatibility Complex located on chromo-
some 6p21 has a complex allelic structure with extended linkage
disequilibrium (LD) and polymorphism. The traditional human
leukocyte antigen (HLA) genes encode the cell-surface antigen-
presenting proteins, the HLA molecules, and fall into two major
MHC classes; Class I (HLA-A, -C, and -B) and Class II (HLA-
DRB1, -DQB1, and –DPB1). Many non-HLA genes related to
immune responses e.g. tumor necrosis factor (TNF), lymphotoxin-alpha
(LTA), complement C4 genes (C4A and C4B) and butyrophilin-like protein
2 (BTNL2), are located in the MHC class III region that resides
between the MHC Class I and II regions [1–3]. The location of
recombination hotspots and the length of LD blocks (genomic
fragments inherited together) are population specific [1,4,5].
Interestingly, it has been shown that the Finnish population has
distinctive population substructure compared with other Europe-
ans [6–8].
The HLA genes play a critical role in hematopoietic stem cell
transplantation, and HLA mismatching has been associated with
graft failure and graft-versus-host disease [9,10]. In addition to the
traditional HLA genes, it has been suggested that the HLA-SNP
haplotypes influence on the outcome of the transplantation [11].
The association between MHC and diseases has been known for
decades. The polymorphic HLA-DRB1 has been associated with
several complex and infectious diseases, such as acute coronary
syndrome [12], HSV2 related meningitis [13], type I diabetes,
celiac disease and multiple sclerosis (reviewed in [14]). Recently,
genome wide association analyses (GWA) have increased the
number of MHC gene associations with several drug-induced
hypersensitivity reactions, autoimmune, infectious and inflamma-
tory disorders [15–20] (GWAS Integrator, http://genome.ucsc.
edu). However, the predisposing HLA-alleles are common in the
healthy population. Other genetic and environmental triggers are
required for disease susceptibility [15,21]. Thus, the complexity of
MHC makes the variant(s) responsible for the causal effect difficult
to pinpoint. As the traditional HLA typing is considered rather
expensive and laborious and the analysis of MHC regions is
complex, many studies do not probe MHC associations more
closely. Thus the functionality of the variants remains uncertain
although identification of a specific risk HLA allele could help to
understand a disease and its causality further.
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At present, for transplantation and many diagnostics proposes,
traditional HLA typing still remains as the most used method [14].
De Bakker [22] presented a tag-SNP based HLA-typing method as
an alternative solution for traditional HLA typing. It has promoted
the screening of certain disease related HLA markers [21,23].
However, not only HLA allele and haplotype frequencies [8,24]
but also the SNP content of haplotypes differ in ethnically diverse
populations complicating the imputation process. It is clear that
more information on the precise content of HLA haplotypes is
needed for transplantation, disease association, anthropological,
and epidemiological studies [8,25].
In this study we focused on studying HLA-DRB1 haplotype
structures in a Finnish population. The allelic diversities of other
traditional HLA-genes and selected group of MHC class III genes
were included and extended haplotypes inferred. We aimed to
interpret the haplotype diversities in relation to HLA-DRB1 locus
because of its higher amount of polymorphism when compared to
the other MHC Class II genes (IMGT database, [26]) and its well-
known associations with several complex diseases. The selected
MHC genes TNF, LTA, C4, BTNL2, and HLA-DRA all have been
associated with several autoimmune or infectious diseases, as well.
We hypothesized that the use of longer MHC blocks, rather than
single alleles, could be advantageous when studying the polymor-
phisms in the MHC region.
Materials and Methods
Study Population
The study consists of one hundred and fifty (150) healthy
Finnish individuals who were randomly selected. Description of
the sample set and the DNA extraction has previously been
published by Seppa¨nen et al. [17]. Briefly, samples from 49 males
and 101 females with mean age of 33.7 years (range 18–60), were
used. The local ethical committee (The Ethics Committee:
Department of Medicine, Hospital District of Helsinki and
Uusimaa) approved the study protocol (Dnro 6/E5/
2001,25.1.2001). All the contributors provided the written
informed consent.
Genotyping of HLA Genes
The HLA genotyping and/or analysis was carried out in an EFI
(European Federation for Immunogenetics) accredited HLA
Laboratory. The genotyping of HLA-A, -B and –DPB1 genes were
performed using sequence specific primers (SSP: Olerup SSP AB,
Stockholm, Sweden). The HLA-DRB1 alleles were detected using
sequence based typing (SBT; InvitrogenTM, Life Technologies,
Carlsbad, CA, USA). HLA-DQB1 alleles were detected with a
panel of lanthanide-labeled oligonucleotide probes [27]. The
reactions were performed according to manufacturers’ instructions
giving at least four-digit resolution (for example, HLA-
DRB1*01:01) for HLA-DRB1 and –DPB1, and at least two-digit
resolution (for example, HLA-A*02) for HLA-A, -B and -DQB1. For
resolving ambiguities, high resolution SSPs or SBT HARPs
(heterozygous ambiguity resolving primers) were used. The HLA
alleles were assessed using HLA nomenclature release 3.5.0
(IMGT/HLA database) and carefully interpreted by two persons.
SNP Selection and Genotyping
We aimed to genotyped LTA, TNF, BTNL2 and HLA-DRA
genes with SNPs. All the selected genes were covered entirely
including 59 and 39- flanking regions. SNPs were chosen from the
HapMap database [28] and/or from the public dbSNP database
(http://www.ncbi.nlm.nih.gov/projects/SNP). Information about
the validation status, tagging quality, minor allele frequency
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(.0.01) and gene structure were used for selecting the SNPs.
Altogether seventy-four SNPs were chosen from the two gene
regions, TNF,LTA, (here referred as TNF block) and
BTNL2,HLA-DRA (here referred as BTNL2 block).
SNP genotyping was performed using the Sequenom MassAr-
ray iPLEX system (Sequenom, San Diego, CA, USA). In the
iPLEX assay, the SNP alleles are separated based on the
differences of the single base extension (SBE) products. Manufac-
ture’s instructions were used to design the assays (AssayDesign
software) and to perform the multiplex PCR and the iPLEX
reaction using 9–10 ng of DNA as a template.
The complement C4A and C4B gene copy numbers and a 2-bp
silencing insertion at exon 29 (CT) in C4A gene were analysed by
quantitative genomic realtime-PCR Rotor-Gene 6000 (Corbett
Research, Sydney, Australia) according to Paakkanen et al. [29].
The C4 allotypes were determined by immunofixation [17]. One
subject was excluded from the analysis.
Statistical Analysis
Allele, phenotype and haplotype frequencies were calculated by
direct counting. To detect significant departure from Hardy-
Weinberg equilibrium (p,0.001), Haploview (SNPs) [30] or
ARLEQUIN 3.11 (HLA genes) [31], were used.
SNP haplotypes were constructed using Haploview [30]. Multi-
locus haplotype frequencies and recombination rates were
estimated from allele data using the Bayesian method with
PHASE v. 2.1.1 [32]. The haplotypes were constructed using all
the selected markers simultaneously. Taken into account the small
sample size and to exclude unreliable haplotypes, only haplotypes
greater than 1% (observed more than 3 times) were used in the
analysis [24,33–35].
The LD measures (D9 and r2) were determined using either the
Haploview software (biallelic markers) [30] or the ARLEQUIN
3.11 software (multiallelic markers) [31]. At this step, only one
SNP from a LD block was chosen for further analysis. It has been
shown that for multiallelic loci, D9 estimates the strength of LD
(.0.80 strong LD, 20.5 moderate LD, 20 weak LD) better than
r2 [36]. The R-package ‘ape’ was used to perform a Neighbor-
joining algorithm according to the method of Saitou and Nei [37].
The HapMap data was used for illustrating the recombination
hotspots in the MHC region [28]. The proxy SNPs (r2.0.9) for
genotyped SNPs were detected using software SNAP [38].
Results
Genotyping of HLA-alleles
The HLA alleles and their frequencies are given in parallel with
the phenotype frequency in Table 1. HLA allele distributions
followed the Hardy–Weinberg equation. A total of 91 HLA alleles
(15, 21, 26, 11 and 18 alleles in HLA-A, -B, -DRB1, -DQB1 and -
DPB1, respectively) were noted. In the Finnish population, two
HLA-A alleles accounted for .66% and five HLA-DPB1 alleles for
.91% of the variation at the loci. Allele frequencies of other HLA
loci were more equally distributed. These observations are
consistent with the previous Finnish studies [39,40].
HLA Haplotypes
Three-locus haplotypes between HLA-DRB1 and MHC Class I
(HLA-A and –B; Table 2) and MHC Class II (HLA-DQB1 and -
DPB1; Table 3) were constructed. Haplotypes having frequencies
higher than 1.0% are presented in Table 2 and 3 and compared
with different populations that had reported the A,B,DRB1 and
DQB1,-DPB1,DRB1 haplotypes in The Allele Frequency Net
Database [41–46]. The three most common A,B,DRB1
haplotypes in the Finnish population were
A*03,B*35,DRB1*01:01 (7.1%), A*01,B*08,DRB1*03:01
Table 2. The Finnish A,B,DRB1 haplotype frequencies (.1%) and comparison with other populations [41–46].
Haplotype A,B,DRB1 Finland (n=150) Sami (n=130) [44] Russia (n=207) [46]
Ireland (n =1000)
[41–43]
HLA-A HLA-B HLA-DRB1 f f f f
*01 *08 *03:01 0.040 0.039 0.050 0.09
*02 *07 *15:01 0.035 0.038 – 0.03
*02 *27 *08:01 0.027 0.014 – –
*02 *15 *13:01 0.023 0.031 0.012 –
*02 *15 *04:01 0.019 0.023 – –
*02 *15 *08:01 0.019 – – –
*02 *13 *07:01 0.016 – 0.021 –
*02 *15 *15:01 0.013 – – –
*02 *44 *04:01 0.012 – 0.019 0.04
*02 *40 *13:02 0.011 – – –
*03 *35 *01:01 0.071 0.031 0.033 –
*03 *08 *03:01 0.021 – – –
*03 *15 *08:01 0.017 0.015 – –
*03 *07 *01:01 0.014 – 0.019 –
*03 *07 *13:01 0.012 – – –
*03 *07 *15:01 0.011 0.042 0.047 0.05
*11 *07 *15:01 0.015 – – –
f = frequency.
doi:10.1371/journal.pone.0079690.t002
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(4.0%) and A*02,B*07,DRB1*15:01 (3.5%). The second most
common HLA-DRB1*01:01 haplotype had HLA-B*07 instead of
HLA-B*35. The two-locus haplotypes (DRB1,DPB1,
DQB1,DPB1 and B,DRB1) are presented in Table S1.The
linkage between HLA-DRB1 and HLA-DQB1 was stronger than
between HLA-DRB1 and HLA-DPB1 (Table S2).
SNP Analysis
Altogether 74 SNPs were successfully genotyped. The average
success rate was 99% and no discrepancies were observed.
Fourteen SNPs were excluded due to minor allele frequency
(,0.01) or HWE (,0.001) and five SNPs were excluded as they
were in total LD (r2 = 1) with another SNP. There can be found
several proxy SNPs (SNPs in strong LD) for our SNPs (examples
shown in Table S3) [38]. Many of the proxy SNPs have been
previously associated with diseases (http://www.snp-nexus.org/).
A summary of the accepted SNPs (n= 55) is given in Table S4.
The allele frequencies of our genotyped SNPs did not differ
significantly from the HapMap (CEU population, European
decent) [28], except the twelve SNPs in BTNL2 or HLA-DRA
genes (Table S4). The LD structure of the SNPs (TNF or BTNL2
block) is presented in the Figure S1. As expected, due to the SNP
selection criteria the pairwise LD between SNPs was always r2,1.
Previously using HapMap data [28], high recombination rates
have been observed between HLA-A and –B loci, upstream and
downstream of TNF, in the BTNL2 region and between HLA-
DQB1 and –DPB1 loci (Figure 1A). Here, the recombination rate
estimation was performed using the HLA alleles (HLA-A, -B, -
DRB1, -DQB1, -DPB1), C4 gene copy numbers and SNPs (n= 55).
Thirty-one SNPs were common in both HapMap and in our
study. The location of the highest recombination rate in the
Finnish sample was observed in the BTNL2 promoter region
corresponding to HapMap data (Figures 1 B and C).
Haplotypes of TNF, BTNL2 and C4
SNP haplotypes were constructed. The rare haplotypes
(observed less than 3 times i.e. frequency ,1%) were excluded
at this point. Nine 13-SNP haplotypes of TNF block (Table 4) and
twelve 42-SNP haplotype of BTNL2 block (Table 6) were observed
with frequencies ranging from 3% to 21% and 1.3% to 15%,
respectively. In both regions, there seemed to be four to five
common haplotypes of almost equal frequency in addition to the
less common haplotypes. C4A and C4B gene copy numbers were
constructed into haplotypes and the results are shown in Table 8.
As opposed to TNF and BTNL2 haplotypes, there was one
haplotype, which covered more than half of the observed
Table 3. The Finnish DRB1,DQB1,DPB1 haplotype frequencies (.1%) and comparison with other populations [41–46].
Haplotype DRB1,DQB1,DPB1 Finland (n =150) Ireland (n=250) [41–43] Greece (n=246) [45]
HLA-DRB1 HLA-DQB1 HLA-DPB1 f f f
*01:01 *05:01 *04:02 0.059 0.024 –
*01:01 *05:01 *04:01 0.043 0.028 0.035
*01:01 *05:01 *02:01 0.040 0.011 –
*03:01 *02 *01:01 0.049 0.021 0.014
*03:01 *02 *04:01 0.020 0.098 0.015
*04:01 *03:02 *04:01 0.026 0.013 –
*04:01 *03:02 *04:02 0.016 – –
*04:04 *03:02 *02:01 0.013 – –
*04:08 *03:01 *02:01 0.016 – –
*07:01 *02 *04:01 0.023 0.017 0.014
*08:01 *04 *03:01 0.071 – –
*08:01 *04 *04:01 0.033 – –
*08:01 *04 *04:02 0.014 – –
*09:01 *03:03 *04:02 0.022 – –
*11:01 *03:01 *04:02 0.013 – –
*11:01 *03:01 *04:01 0.012 – 0.036
*11:01 *03:01 *02:01 0.012 – 0.023
*12:01 *03:01 *04:01 0.025 – –
*13:01 *06:03 *04:01 0.027 0.014 0.016
*13:01 *06:03 *02:01 0.023 – 0.023
*13:01 *06:03 *05:01 0.012 – –
*13:02 *06:04 *03:01 0.030 – –
*13:02 *06:04 *04:02 0.013 – –
*15:01 *06:02 *04:01 0.090 0.149 0.015
*15:01 *06:02 *04:02 0.020 – –
*15:01 *06:02 *05:01 0.014 – –
f = frequency.
Total number of haplotypes in the population sample (Haplotypes/2n) shown in frequencies (f).
doi:10.1371/journal.pone.0079690.t003
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haplotypes (C4_1 haplotype, 59%). The frequency of the next
common haplotype was less than 20%, showing a sharp decrease.
The significant pair-wise LD [(D9.0.80, r2.0.35, P value (P)
,0.05)] between HLA-DRB1 alleles and other markers is
presented in Table 10. The HLA-DRB1 allele distribution (%)
presented in Table S2 shows how HLA-DRB1 alleles are clustered
with MHC class I, II and III alleles and MHC blocks.
The linkage between HLA-DRB1 and TNF block (Table 5)
indicates that a given HLA-DRB1 allele was combined with
different TNF blocks. Two cases, HLA-DRB1*03:01 and TNF_3
and HLA-DRB1*13:02 and TNF_9 showed strong LD (D9=0.80;
D9=0.88, respectively, Table 10).
Contrary to TNF block, the linkage between HLA-DRB1 and
BTNL2 block (Table 7) showed that mostly HLA-DRB1 alleles
(*01:01, *03:01, *04:01, *08:01, *11:01, *13:02 and *15:01) were
strongly linked with BTNL2 blocks (Table 10, Table S2). However,
there were some exceptions such as HLA-DRB1 *12:01 and *13:01
(Table S2).
The DRB1,C4 haplotypes behaved like the DRB1,TNF
haplotypes showing association with different HLA-DRB1 alleles
(Table 9). C4B null allele (haplotypes C4_2 and C4_3) were found
with DRB1*01:01, *04:01, *08:01 and *13:01. HLA-DRB1*03:01
had C4AQ0 (C4_4; D9=0.73; Table 10), but also a haplotype
without a C4A null allele (C4_1) was observed. HLA-DRB1*13:02
Figure 1. Recombination rates in MHC region. 1A: The recombination rates for (HapMap [28]) in MHC region. 1B: Recombination rates in
HapMap [28] for the 31 SNPs that are common in the current study and HapMap. 1C: Recombination rates for the 31 SNPs in the study (that are
common in the study and HapMap [28])). The highest recombination rate was observed in the BTNL2 promoter region.
doi:10.1371/journal.pone.0079690.g001
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had typically an insertion in the C4A gene (C4_5; D= 0.90
Table 10).
To summarize the LD and haplotype analysis and to the
polymorphism of the MHC region and its relation to HLA-DRB1,
an additional four-locus haplotype (HLA-DRB1, TNF block,
BTNL2 block and C4; Table 11) and a six-locus haplotype
(HLA-DRB1, HLA-B, TNF block, BTNL2 block, C4A and C4B
allotypes; Table S5) were performed. The results showed that the
extended HLA-DRB1 haplotypes were broken down when HLA-B,
C4 allotypes and TNF block were taken into account.
To further analyze the structure of TNF and BTNL2 blocks we
created phylogenetic trees of the genetic distance using sequence
similarities (Figure S2). Three branches of TNF were observed,
from which two branches, TNF_3 and _9 formed haplotypes with
HLA-DRB1*03:01 and HLA-DRB1*13:02, respectively, which we
previously showed with high LD. The third branch divided into
three groups, first with TNF_2, second with TNF_4, _5 and _8 and
third with TNF_1, _6, and _7. C4BQ0 related TNF haplotypes,
TNF_2 and TNF_4, belonged to the same main branch. The
phylogenetic tree of BTNL2 blocks showed that BTNL2_5 and _7
(in linkage with HLA-DRB1*03:01 and *13:02, respectively) and
BTNL2_6 (in linkage with HLA-*13:01) had different BTNL2
block structure than the rest. HLA-DRB1*12:01 alleles had either
BTNL2 blocks BTNL2_10 or _11. HLA-DRB1*11:01 and *15:01
had structurally similar BTNL2 blocks, BTNL2_8 and _2,
respectively. HLA-DRB1*01:01, HLA-DRB1*04 alleles and HLA-
DRB1*07:01 and *08:01 formed a wide branch with similar
BTNL2 blocks _3, _4, and _8, _10 and _11 (in linkage with HLA-
DRB1*01:01, *04:01-08, *07:01, *08:01, *11:01, *12:01, *15:01)
and BTNL2_9 (in linkage with HLA-DRB1*13:01).
Discussion
To our knowledge, no extensive study exist that combines
information from HLA-A,-B,-DRB1,-DQB1 and –DPB1 alleles with
TNF, BTNL2 and complement C4 blocks. In this study, we
addressed (i) the diversity of extended HLA-DRB1 haplotypes
covering the MHC class I, II and III regions, (ii) the shared MHC
or SNP markers in extended HLA-DRB1 haplotypes, and (iii) the
challenge in detecting causal variants in the HLA data.
The most common Finnish A,B,DR –haplotype was
A*03,B*35,DRB1*01:01. Also other HLA-DRB1*01:01 haplo-
types with variable levels of LD were observed. According to The
Allele Frequency Net Database [41], only in a few populations e.g.
the Swedish Sami [44] and Russia [46] the
A*03,B*35,DRB1*01:01 was found with the frequency .2%.
In Finland, the second most common haplotype was
A*01,B*08,DRB1*03:01 in high LD. This haplotype is not so
common in Finns as in other Europeans and has been previously
referred as the ancestral haplotype AH 8.1 or autoimmune
Table 4. TNF blocks (TNF_1– TNF_9) and their frequencies (.1.0%).HLA-DRB1 Haplotypes with TNF, BTNL2 and C4 Blocks.
SNP TNF_1 TNF_2 TNF_3 TNF_4 TNF_5 TNF_6 TNF_7 TNF_8 TNF_9
rs2009658 C C C C G C C G C
rs2239704 A C C C C A A C C
rs2229094 T T T C C T T C T
rs2229092 A A A A A A A C A
rs1041981 C A A C C C C C A
rs1799964 T T T T C T T C T
rs1799724 C C C C C C T C C
rs1800629 G G A G G G G G G
rs361525 G G G G G G G G G
rs3093664 A A A A A A A A G
rs769178 G G G G G G T G G
rs3093553 T T T T T T T T T
rs2256965 A G G A G G A G G
F 0.210 0.167 0.153 0.130 0.090 0.080 0.057 0.047 0.030 0.96#
doi:10.1371/journal.pone.0079690.t004
Table 5. Two-locus haplotypes of HLA-DRB1 with TNF block
(.1.0%)#.
DRB1 allele TNF block f
*01:01 TNF_4 0.103
*03:01 TNF_3 0.076
*04:01 TNF_2 0.022
*04:01 TNF_5 0.027
*04:08 TNF_1 0.016
*07:01 TNF_1 0.040
*08:01 TNF_1 0.027
*08:01 TNF_2 0.048
*08:01 TNF_6 0.030
*09:01 TNF_6 0.025
*11:01 TNF_3 0.014
*13:01 TNF_1 0.017
*13:01 TNF_2 0.035
*13:02 TNF_9 0.026
*15:01 TNF_1 0.075
*15:01 TNF_4 0.016
*15:01 TNF_7 0.014
f = frequency.
#Rare haplotypes were excluded from the analysis.
doi:10.1371/journal.pone.0079690.t005
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haplotype [47,48]. Another conserved haplotype with strong LD,
but rare in the Finnish population, was HLA-DRB1*13:02
reaching from TNF to HLA-DQB1.
The enrichment or loss of certain HLA haplotypes (Table 2)
reflects the characteristics of the Finnish population structure,
which has evolved through multiple genetic bottlenecks [6,7].
Detailed information of population substructures was presented by
the 16th International HLA and Immunogenic Workshop IHIW
project (‘‘Analysis of HLA Population Data’’ [8]. Most impor-
tantly, the multidimensional scaling (MDS) of HLA-DRB1 revealed
Table 6. BTNL2 blocks (BTNL2_1– BTNL2_12) and their frequencies (.1.0%).
SNP BTNL2_1 BTNL2_2 BTNL2_3 BTNL2_4 BTNL2_5 BTNL2_6 BTNL2_7 BTNL2_8 BTNL2_9 BTNL2_10 BTNL2_11 BTNL2_12
rs28362678 T C C C C T C C C C C C
rs2076530 C T C T T C T T T T T T
rs9268480 C C T C C C C C C C C C
rs2076529 C T C T T C T T T T T T
rs3793127 C C T C C C C C C C C C
rs28362683 G G G A G A G G G G G G
rs3763311 C C T C C C C C C C C C
rs3763312 G G A G G G G G G G G G
rs3763313 C A A C A A A A A A A C
rs3763317 T C T T C C C C C C C T
rs5007259 C T C C T T T T T T T C
rs17208888 G G G G G G G A G G G G
rs9405098 G G G G G G G G G G G G
rs9268528 A A G A A A A G A G G A
rs9268541 T T T T T T T T T C C T
rs2395166 C C T T T T T T T T T C
rs3135365 T G T T T T T T T T T T
rs3135363 T T T T C C C C C T T T
rs3135351 G G G G T T T G T G G G
rs3135344 G G A A A A A A A A A G
rs3129843 A A A A G A A A A A A A
rs3135341 T G T T T T T T T T T G
rs2027856 C C C T C C C C C C C C
rs3129871 C A C A C A C C C A A A
rs9405035 G G G G G G G G G G G G
rs9268644 A A C C A A A C A A C C
rs3129877 A G G G A A A G A G G G
rs3135392 T G G T T T T G T T T T
rs3129882 A G A G A A A G A G G G
rs8084 C A C A A A A A A A A A
rs2239804 A A G A A A A G A A A A
rs11544315 G G G G G G G G G G G A
rs3177928 A G G G G G G G G G G A
rs3135388 C T C C C C C C C C C C
rs2213585 T C T C C C C T C C C T
rs6937545 C A C C A A A C A C C C
rs9268833 C C T C C C C C C C C C
rs6919855 T C T T T T T C T T T T
rs7766843 C C C T T T T C T T T C
rs2395185 G G T G G G G G G G G T
rs9268979 T T C C C C C T C C C C
rs7748472 A A A A A A G A A A A A
f 0.150 0.143 0.137 0.103 0.097 0.053 0.040 0.040 0.020 0.020 0.017 0.013
doi:10.1371/journal.pone.0079690.t006
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that the Finns and the Sami are closer to the North-East Asians
than to other European populations [8]. In general, the HLA
variation in Europe follows the North to Southeast axis
corresponding to the previous principal component analysis
(PCA) based results that utilized genome-wide SNP data [7].
Interestingly in Finland, the prevalence of certain HLA alleles
have shown regional differences [40] e.g. HLA-B*35 being highest
in the Eastern parts of Finland. Also GWASs have shown similar
trends [7]. The HLA haplotype deviations in relation to the
Finnish population substructure warrant replication studies. The
population stratification is important e.g. for control selection [34].
We found that the majority of HLA-DRB1 alleles were inherited
as extended blocks from BTNL2 to HLA-DQB1. In spite of the
observed recombination rate in the BTNL2 promoter region, most
DRB1,BTNL2 blocks appeared to be conserved. Including HLA-
B, TNF, C4 and HLA-DPB1 the number of extended HLA-DRB1
haplotypes strongly increased. The positions of the MHC
recombination sites vary between populations [49] explaining
partly the non-replication of disease associations between popu-
lations (e.g. [19,50,51]).
Our multi-locus haplotype analysis shows that the extended
HLA-DRB1 haplotypes can be grouped according to functional
similarities. Especially interesting for disease association studies are
the HLA-DRB1 haplotypes not common in the general population.
Furthermore, TNF and LTA genes are cytokines involved in the
activation of inflammatory processes; hence the HLA-DRB1
haplotypes with gene expression related SNPs (rs2239704,
rs1041981 and rs1800629) [2,52] are plausible candidates for
inflammatory diseases. For example, a rare HLA-
DRB1*15:01,TNF_4 haplotype has a different nucleotide in
rs2239704 compared with more frequent HLA-
DRB1*15:01,TNF haplotypes. Interestingly, the same TNF_4 is
also found with HLA-DRB1*01:01 shown to be associated with
inflammatory reactions [53]. The extended HLA-DRB1 haplotypes
of HLA-DRB1*03:01, *08:01, *11:01, *12:01, *13:02 and *15:01
can be grouped according to exonic missense SNP (rs2076530)
causing truncated protein of the T-cell inhibitor BTNL2 [19]. Of
the complement C4 proteins, the C4A null alleles were primarily
found with two conserved haplotypes, HLA-DRB1*03:01 (AH 8.1)
and HLA-DRB1*13:02. C4B null alleles were characteristically
inherited with the most common Finnish haplotype
A*03,B*35,DRB1*01:01 or with HLA-DRB1*04:01, *08:01
and *13:01. C4 null alleles have shown to be related to many
diseases [18]. Taken together, the extended HLA-DRB1 haplotype
analysis can reveal predisposing/protective associations between
markers and disease loci not detectable with a single MHC allele
[34].
Overall, analysis of immunogenomic data is challenging.
Resolving HLA allele ambiguity, phasing and LD calculation
warrant particular expertise, and the traditional software tools (e.g.
Haploview and PLINK) are not suitable for multiple loci
polymorphic data like HLA [34,54]. Haplotypes rather than
single markers were used to decrease phasing errors [55]. Due to
the strong LD, multiple SNPs may have corresponding statistical
Table 7. Two-locus haplotypes of HLA-DRB1 with BTNL2 block
(.1.0%)#.
HLA-DRB1 BTNL2 block f
*01:01 BTNL2_1 0.147
*03:01 BTNL2_5 0.097
*04:01 BTNL2_3 0.064
*04:03 BTNL2_3 0.013
*04:08 BTNL2_3 0.020
*07:01 BTNL2_3 0.023
*07:01 BTNL2_12 0.013
*08:01 BTNL2_4 0.103
*11:01 BTNL2_8 0.037
*12:01 BTNL2_10 0.020
*12:01 BTNL2_11 0.016
*13:01 BTNL2_6 0.053
*13:02 BTNL2_7 0.040
*15:01 BTNL2_2 0.143
#Rare haplotypes were excluded.
f = frequency.
doi:10.1371/journal.pone.0079690.t007
Table 8. C4 blocks (C4_1– C4_6) and their frequencies
(.1.0%).
C4 gene C4_1 C4_2 C4_3 C4_4 C4_5 C4_6
C4A 1 2 1 Q0 InsCT 2
C4B 1 Q0 Q0 1 1 1
f 0.59 0.17 0.09 0.08 0.03 0.03
doi:10.1371/journal.pone.0079690.t008
Table 9. Two-locus haplotypes of HLA-DRB1 with C4 block
(.1.0%)#.
HLA-DRB1 C4 block f
*01:01 2 0.083
*01:01 1 0.032
*01:01 3 0.029
*03:01 4 0.068
*03:01 1 0.022
*04:01 1 0.038
*04:01 2 0.026
*04:04 1 0.019
*04:08 1 0.019
*07:01 1 0.046
*08:01 1 0.082
*08:01 3 0.041
*09:01 1 0.029
*11:01 1 0.036
*12:01 1 0.024
*13:01 1 0.045
*13:01 2 0.032
*13:02 5 0.030
*15:01 1 0.120
*15:01 6 0.016
#Rare haplotypes were excluded.
Q0 =null allele.
InsCT = insertion in C4A gene.
f = frequency.
doi:10.1371/journal.pone.0079690.t009
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proof of association making the search for possible causal variants
exceptionally difficult. To clarify the complexity, the known tag-
SNP for HLA-DRB1*15:01 (rs3135388) (see Figure S3), was shown
to have at least 20 proxy SNPs (r2.0.9) with variable function and
in different gene regions [14,22,38]. The SNPs’ allele frequency
might be also population specific (rs2213585; Table S4), and thus
the tag-SNPing (i.e. imputation) should not be used unless the
ethnic background is known [56]. Here in this material, except the
tag-SNP for HLA-DRB1*15:01 (rs3135388) [14,22], we did not
detect any single tag-SNP for a specific HLA-DRB1 allele. Indeed,
large population specific cohorts and dense SNP genotyping is
needed for detecting HLA tag-SNPs.
We acknowledge that the multiple ambiguous alleles, limited
sample size, and rare HLA alleles can influence the haplotype
phasing and LD leading to false positive results [34]. In case of
small sample size, the study of the rare MHC haplotypes is
challenging. Thus, we presented only frequent MHC haplotypes
(.1%) and interpreted the LD between markers carefully
[34,35,54,55,57]. The HLA allele distributions were consistent
with the previously published Finnish registry studies [39,40]
suggesting that the Finnish HLA profile can be estimated with a
sample set containing 150 individuals.
One of the limitations of this study was the lack of genome-wide
SNP data. Hence, we were not able to use HLA*IMP [58] for
allele imputation or analyse the HLA tagging SNPs in the Finnish
populations [22]. Because of the differences between populations,
population specific validation is highly recommended before using
either the HLA*IMP or the HLA tagging SNPs [7,14,23].
Taken together, we stress the importance of understanding the
population specific MHC haplotypes and the analysis of immu-
nogenetic data. The study of extended HLA-DRB1 haplotypes
indicates the functionality of the implicated genes and provides
hypotheses for further assessment of HLA-DRB1. The results
presented here assist for disease association studies focusing in
chronic inflammatory, autoimmune and infectious diseases.
Supporting Information
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Table 11. The extended HLA-DRB1 haplotypes with TNF, C4
and BTNL2 blocks (.1%).
HLA-DRB1 TNF block C4 block BTNL2 block f
*01:01 TNF_4 2 BTNL2_1 0.059
*01:01 TNF_4 3 BTNL2_1 0.026
*01:01 TNF_4 1 BTNL2_1 0.017
*01:01 TNF_8 2 BTNL2_1 0.012
*03:01 TNF_3 4 BTNL2_5 0.065
*03:01 TNF_3 1 BTNL2_5 0.011
*04:01 TNF_5 1 BTNL2_3 0.024
*04:01 TNF_2 2 BTNL2_3 0.022
*04:08 TNF_1 1 BTNL2_3 0.013
*07:01 TNF_1 1 BTNL2_3 0.023
*08:01 TNF_6 1 BTNL2_4 0.028
*08:01 TNF_2 1 BTNL2_4 0.022
*08:01 TNF_2 3 BTNL2_4 0.022
*08:01 TNF_1 1 BTNL2_4 0.016
*11:01 TNF_5 1 BTNL2_8 0.011
*13:01 TNF_2 2 BTNL2_6 0.014
*13:01 TNF_1 1 BTNL2_6 0.012
*13:02 TNF_9 5 BTNL2_7 0.027
*15:01 TNF_1 1 BTNL2_2 0.059
*15:01 TNF_7 1 BTNL2_2 0.016
*15:01 TNF_5 1 BTNL2_2 0.012
f = haplotype frequency.
doi:10.1371/journal.pone.0079690.t011
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